All Stories

  1. Visualization and Grading of Vitreous Floaters Using Dynamic Ultra-Widefield Infrared Confocal Scanning Laser Ophthalmoscopy: A Pilot Study
  2. Topical Triamcinolone Acetonide-Loaded Liposome Formulation Used as an Adjuvant to Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration
  3. Fundus autofluorescence in premature infants
  4. Intravitreal quantum dots for retinitis pigmentosa: a first-in-human safety study
  5. Survey of Intravitreal Injection Techniques Among Retina Specialists in Mexico
  6. Treatment of Capillary Hemangioblastoma in Von Hippel-Lindau Disease: Case Report and Online Survey of Treatment Preferences among Experts
  7. A Proposed Method to Quantify Vitreous Hemorrhage by Ultrasound
  8. One hundred years of history and thirty together
  9. Cilioretinal artery branch avulsion secondary to surgical embolectomy: Management and outcome
  10. Anti-VEGF treatment switch in neovascular age-related macular degeneration: a comparison of aflibercept versus ranibizumab after a single-dose switch
  11. Photodynamic therapy combined with intravitreal bevacizumab for the management of choroidal neovascularization resistant to bevacizumab monotherapy. A case series
  12. Conservative management of penetrating ocular trauma caused by a nail gun
  13. Micropulse laser for persistent optic disc pit maculopathy. A case report
  14. A new change, new opportunities
  15. Cilioretinal artery branch avulsion secondary to surgical embolectomy: management and outcome. Case report
  16. Imagen de retina de campo ultra-amplio
  17. Sensitivity, specificity and predictive values of anterior chamber tap in cases of bacterial endophthalmitis
  18. Double Staining Technique With Brilliant Blue G and Its Effect on Ganglion Cells in Macular Pathology
  19. Neuroretinitis
  20. Pars Planitis
  21. Cavernous Hemangioma of the Retina
  22. Ophthalmology: Current and Future Developments
  23. Retinal Vasoproliferative Tumor
  24. Melanocytoma
  25. Congenital Hypertrophy of the Retinal Pigment Epithelium
  26. Traumatic Macular Hole
  27. Rhegmatogenous Retinal Detachment
  28. X-Linked Juvenile Retinoschisis
  29. Chorioretinal Coloboma
  30. Ophthalmology: Current and Future Developments
  31. Retinitis Pigmentosa
  32. Mejorando la calidad de los reportes en investigación
  33. Evaluation of VEGF gene polymorphisms and proliferative diabetic retinopathy in Mexican population
  34. Vascular changes on fluorescein angiography of premature infants with low risk of retinopathy of prematurity after high oxygen exposure
  35. Tiempo de cambios
  36. Branch Retinal Vein Occlusion
  37. Wet Age-Related Macular Degeneration
  38. Ophthalmology: Current and Future Developments
  39. Long-term follow-up of patients with choroidal neovascularization due to angioid streaks
  40. New insights in diagnosis and treatment for Retinopathy of Prematurity
  41. Effect of Caffeine Intake on Retinal Microsurgical Performance
  42. Acute sterile endophthalmitis following intravitreal bevacizumab: case series
  43. Comparison of iridocorneal angle in infants with retinopathy of prematurity and healthy infants using spectral domain optical coherence tomography
  44. Retinal fluorescein angiographic changes following intravitreal anti-VEGF therapy
  45. Macular optical coherence tomography findings and GPR143 mutations in patients with ocular albinism
  46. Intravitreal Bevacizumab for the Treatment of Chronic or Recurrent Central Serous Chorioretinopathy
  47. Inner Segment Ellipsoid Band and Cone Outer Segment Tips Changes Preceding Macular Hole Development in a Young Patient
  48. Neovascular Glaucoma
  49. Prevalence of Macular Anatomic Abnormalities in High Myopia
  50. LONG-TERM EFFECT OF ANTIANGIOGENIC THERAPY FOR RETINOPATHY OF PREMATURITY Up to 5 Years of Follow-up
  51. Growth of Scytalidium sp. in a counterfeit bevacizumab bottle
  52. Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity
  53. MULTIFOCAL ELECTROPHYSIOLOGIC FINDINGS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENT
  54. Intravitreal bevacizumab versus panretinal photocoagulation for treatment-naïve proliferative and severe nonproliferative diabetic retinopathy
  55. Perfluorocarbon-perfused 23 gauge three-dimensional vitrectomy for complicated diabetic tractional retinal detachment
  56. Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
  57. Reduction of Fluence to Decrease Pain During Panretinal Photocoagulation in Diabetic Patients
  58. Bilateral macular hole formation secondary to sclopetaria caused by shockwaves transmitted by a posterior vector: case report
  59. Retinopathy of prematurity
  60. Chapter-33 Management of Traumatic Subretinal and/or Suprachoroidal Hemorrhage
  61. Bevacizumab Local Complications
  62. BILATERAL CENTRAL RETINA VEIN OCCLUSION ASSOCIATED WITH OBESITY–HYPOVENTILATION SYNDROME (PICKWICKIAN SYNDROME)
  63. TRACTIONAL RETINAL DETACHMENT AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB IN PROLIFERATIVE DIABETIC RETINOPATHY
  64. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (Case reports)
  65. Correspondence
  66. PERFLUOROCARBON-PERFUSED VITRECTOMY USING A TRANSCONJUNCTIVAL 25-GAUGE SYSTEM
  67. In vivo architectural analysis of 3.2 mm clear corneal incisions for phacoemulsification using optical coherence tomography
  68. Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy—a safety and feasibility study
  69. Perfluorocarbon perfused vitrectomy: animal studies
  70. Perfluorocarbon-Perfused 25-Gauge Vitrectomy